Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Imschweiler

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Praxis|April 27, 2017
Christian Salvisberg, Waldemar Bartkowicki, Thomas Imschweiler, et al.
European Radiology|August 28, 2013
MRI-guided vacuum-assisted breast biopsy: comparison with stereotactically guided and ultrasound-guided techniquesThomas Imschweiler, Harald Haueisen, Gert Kampmann, et al.
Pediatric Blood & Cancer|September 18, 2010
An aggressive systemic juvenile xanthogranuloma clonally related to a preceding T-cell acute lymphoblastic leukemiaRuy Perez-Becker, Monika Szczepanowski, Ivo Leuschner, et al.
Leukemia & Lymphoma|July 4, 2018
Daunorubicin during delayed intensification decreases the incidence of infectious complications - a randomized comparison in trial CoALL 08-09Franziska Schramm, Martin Zimmermann, Norbert Jorch, et al.
Lancet (London, England)|November 22, 2025
Catch-up growth after switch to asciminib in a twin with chronic myeloid leukaemiaStephanie Sembill, Michaela Marx, Ivana Eikelberg, et al.
Haematologica|August 5, 2021
Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study GroupGabriele Escherich, Udo Zur Stadt, Arndt Borkhardt, et al.
Pediatric Blood & Cancer|September 21, 2022
Amsacrine combined with etoposide and methylprednisolone is a feasible and safe component in first-line intensified treatment of pediatric patients with high-risk acute lymphoblastic leukemia in CoALL08-09 trialKerstin Mezger, Sabine Ebert, Hannah Elisa Muhle, et al.
Blood Advances|November 26, 2019
Results of CoALL 07-03 study childhood ALL based on combined risk assessment by in vivo and in vitro pharmacosensitivityFranziska Schramm, Udo Zur Stadt, Martin Zimmermann, et al.
The Oncologist|March 10, 2019
Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT SeriesMartin Benesch, Martin Mynarek, Hendrik Witt, et al.
Journal of Medical Genetics|September 9, 2019
High-sensitivity microsatellite instability assessment for the detection of mismatch repair defects in normal tissue of biallelic germline mismatch repair mutation carriersMaribel González-Acosta, Fátima Marín, Benjamin Puliafito, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Praxis|April 27, 2017
Christian Salvisberg, Waldemar Bartkowicki, Thomas Imschweiler, et al.
European Radiology|August 28, 2013
MRI-guided vacuum-assisted breast biopsy: comparison with stereotactically guided and ultrasound-guided techniquesThomas Imschweiler, Harald Haueisen, Gert Kampmann, et al.
Pediatric Blood & Cancer|September 18, 2010
An aggressive systemic juvenile xanthogranuloma clonally related to a preceding T-cell acute lymphoblastic leukemiaRuy Perez-Becker, Monika Szczepanowski, Ivo Leuschner, et al.
Leukemia & Lymphoma|July 4, 2018
Daunorubicin during delayed intensification decreases the incidence of infectious complications - a randomized comparison in trial CoALL 08-09Franziska Schramm, Martin Zimmermann, Norbert Jorch, et al.
Lancet (London, England)|November 22, 2025
Catch-up growth after switch to asciminib in a twin with chronic myeloid leukaemiaStephanie Sembill, Michaela Marx, Ivana Eikelberg, et al.
Haematologica|August 5, 2021
Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study GroupGabriele Escherich, Udo Zur Stadt, Arndt Borkhardt, et al.
Pediatric Blood & Cancer|September 21, 2022
Amsacrine combined with etoposide and methylprednisolone is a feasible and safe component in first-line intensified treatment of pediatric patients with high-risk acute lymphoblastic leukemia in CoALL08-09 trialKerstin Mezger, Sabine Ebert, Hannah Elisa Muhle, et al.
Blood Advances|November 26, 2019
Results of CoALL 07-03 study childhood ALL based on combined risk assessment by in vivo and in vitro pharmacosensitivityFranziska Schramm, Udo Zur Stadt, Martin Zimmermann, et al.
The Oncologist|March 10, 2019
Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT SeriesMartin Benesch, Martin Mynarek, Hendrik Witt, et al.
Journal of Medical Genetics|September 9, 2019
High-sensitivity microsatellite instability assessment for the detection of mismatch repair defects in normal tissue of biallelic germline mismatch repair mutation carriersMaribel González-Acosta, Fátima Marín, Benjamin Puliafito, et al.
Pageof 2